BRPI0106382B1 - Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions - Google Patents
Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions Download PDFInfo
- Publication number
- BRPI0106382B1 BRPI0106382B1 BRPI0106382-0A BR0106382A BRPI0106382B1 BR PI0106382 B1 BRPI0106382 B1 BR PI0106382B1 BR 0106382 A BR0106382 A BR 0106382A BR PI0106382 B1 BRPI0106382 B1 BR PI0106382B1
- Authority
- BR
- Brazil
- Prior art keywords
- obtaining
- vitis
- lyophilisate
- extract
- ethyl acetate
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 235000004282 Vitis labrusca Nutrition 0.000 title claims abstract description 38
- 230000008569 process Effects 0.000 title claims abstract description 33
- 244000070384 Vitis labrusca Species 0.000 title claims description 39
- 240000006365 Vitis vinifera Species 0.000 title claims description 28
- 235000014787 Vitis vinifera Nutrition 0.000 title claims description 27
- 235000002532 grape seed extract Nutrition 0.000 title claims description 27
- 239000000399 hydroalcoholic extract Substances 0.000 title claims description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000284 extract Substances 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 235000013399 edible fruits Nutrition 0.000 claims description 21
- 239000002024 ethyl acetate extract Substances 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 14
- 239000011148 porous material Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 9
- 230000003285 pharmacodynamic effect Effects 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 6
- 229920002261 Corn starch Polymers 0.000 claims description 5
- 239000008120 corn starch Substances 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000002803 maceration Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 229940099112 cornstarch Drugs 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 239000012675 alcoholic extract Substances 0.000 claims 1
- 239000010903 husk Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000002879 macerating effect Effects 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 241000700159 Rattus Species 0.000 abstract description 26
- 206010020772 Hypertension Diseases 0.000 abstract description 25
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract description 18
- 238000011282 treatment Methods 0.000 abstract description 17
- 208000037849 arterial hypertension Diseases 0.000 abstract description 11
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 239000002775 capsule Substances 0.000 abstract description 9
- 238000003786 synthesis reaction Methods 0.000 abstract description 9
- 230000004872 arterial blood pressure Effects 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 241000219095 Vitis Species 0.000 abstract 1
- 235000009392 Vitis Nutrition 0.000 abstract 1
- 241001512058 Vitis labrusca x Vitis vinifera Species 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000002269 spontaneous effect Effects 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 33
- 239000000047 product Substances 0.000 description 24
- 230000036772 blood pressure Effects 0.000 description 23
- 239000000203 mixture Substances 0.000 description 20
- 239000003651 drinking water Substances 0.000 description 16
- 235000020188 drinking water Nutrition 0.000 description 16
- 239000012071 phase Substances 0.000 description 16
- 230000003276 anti-hypertensive effect Effects 0.000 description 15
- KCWZGJVSDFYRIX-YFKPBYRVSA-N N(gamma)-nitro-L-arginine methyl ester Chemical compound COC(=O)[C@@H](N)CCCN=C(N)N[N+]([O-])=O KCWZGJVSDFYRIX-YFKPBYRVSA-N 0.000 description 13
- 238000009835 boiling Methods 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 230000006978 adaptation Effects 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 239000007791 liquid phase Substances 0.000 description 10
- 230000007935 neutral effect Effects 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- 241000700157 Rattus norvegicus Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 230000001631 hypertensive effect Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- VPGRYOFKCNULNK-ACXQXYJUSA-N Deoxycorticosterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)COC(=O)C)[C@@]1(C)CC2 VPGRYOFKCNULNK-ACXQXYJUSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 238000013059 nephrectomy Methods 0.000 description 2
- 238000011458 pharmacological treatment Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 125000002059 L-arginyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000750042 Vini Species 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000678 effect on lipid Effects 0.000 description 1
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Table Devices Or Equipment (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Extraction Or Liquid Replacement (AREA)
- Medicinal Preparation (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0106382-0A BRPI0106382B1 (pt) | 2001-03-13 | 2001-03-13 | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions |
| DE60213211T DE60213211T2 (de) | 2001-03-13 | 2002-03-12 | Verfahren zur gewinnung von dekokten aus schalen von vitis labrusca und vitis vinifera |
| PCT/BR2002/000038 WO2002072118A1 (en) | 2001-03-13 | 2002-03-12 | Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| JP2002571077A JP2004525124A (ja) | 2001-03-13 | 2002-03-12 | ヴィティスラブルスカおよびヴィティスヴィニフェラの果皮の浸出物を得るためのプロセス |
| PT02702184T PT1368045E (pt) | 2001-03-13 | 2002-03-12 | Processo para obtenção de decoctos de cascas de vitis labrusca e vitis vinifera |
| US10/469,990 US20040202737A1 (en) | 2001-03-13 | 2002-03-12 | Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| AT02702184T ATE333283T1 (de) | 2001-03-13 | 2002-03-12 | Verfahren zur gewinnung von dekokten aus schalen von vitis labrusca und vitis vinifera |
| ES02702184T ES2269650T3 (es) | 2001-03-13 | 2002-03-12 | Procedimiento para la obtencion de decocciones de piel de vitis labrusca y vitis vinifera. |
| MXPA03008161A MXPA03008161A (es) | 2001-03-13 | 2002-03-12 | Proceso para la obtencion de decocciones de las pieles de vitis labrusca y vits vinifera. |
| EP02702184A EP1368045B1 (en) | 2001-03-13 | 2002-03-12 | Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| CA002440333A CA2440333C (en) | 2001-03-13 | 2002-03-12 | Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0106382-0A BRPI0106382B1 (pt) | 2001-03-13 | 2001-03-13 | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0106382A BR0106382A (pt) | 2003-09-30 |
| BRPI0106382B1 true BRPI0106382B1 (pt) | 2017-07-11 |
| BRPI0106382B8 BRPI0106382B8 (https=) | 2021-05-25 |
Family
ID=36782358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0106382-0A BRPI0106382B1 (pt) | 2001-03-13 | 2001-03-13 | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040202737A1 (https=) |
| EP (1) | EP1368045B1 (https=) |
| JP (1) | JP2004525124A (https=) |
| AT (1) | ATE333283T1 (https=) |
| BR (1) | BRPI0106382B1 (https=) |
| CA (1) | CA2440333C (https=) |
| DE (1) | DE60213211T2 (https=) |
| ES (1) | ES2269650T3 (https=) |
| MX (1) | MXPA03008161A (https=) |
| PT (1) | PT1368045E (https=) |
| WO (1) | WO2002072118A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001122791A (ja) | 1999-10-20 | 2001-05-08 | Boehringer Ingelheim Internatl Gmbh | 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤 |
| EP1572221A1 (en) * | 2002-12-20 | 2005-09-14 | Council of Scientific and Industrial Research | Ayurvedic herbal soft drink |
| AU2003298180B2 (en) * | 2002-12-31 | 2010-01-21 | Boehringer Ingelheim International Gmbh | Film coated tablet comprising an extract of red vine leaves |
| JP2007523110A (ja) | 2004-02-19 | 2007-08-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 赤ブドウ葉の抽出物および抗炎症剤を含む、慢性静脈疾患を治療するための組成物 |
| BRPI0604281A (pt) * | 2006-07-18 | 2008-03-04 | Roberto Soares De Moura | processo para obtenção de decotos de frutos e caroços de euterpe oleracea (açaì) processo de obtenção de extratos hidro-alcoólicos a partir dos decotos; processo obtenção de liofilizado e/ou spray dryer do extrato hidro-alcoólico; composições farmacêuticas contendo os liofilizados e/ou spray dryer dos ditos extratos e uso terapêutico das composições como vasodilatador no tratamento das sìndromes isquêmicas, vaso-espásticas e da hipertenção arterial |
| JP5892436B2 (ja) * | 2011-08-26 | 2016-03-23 | ビーエイチエヌ株式会社 | 血圧降下剤 |
| KR102155113B1 (ko) * | 2019-10-30 | 2020-09-11 | 유한회사 한풍제약 | 고혈압 치료용 약학적 조성물 및 식품 조성물 |
| JP6953054B1 (ja) * | 2021-03-31 | 2021-10-27 | Ｄｅｌｔａ−Ｆｌｙ Ｐｈａｒｍａ株式会社 | 湿度に敏感な医薬用途物質を安定化する方法及び安定製剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2092743A1 (en) * | 1970-06-15 | 1972-01-28 | Aquitaine Invest Pharma | Complete extraction of total flavanol gomers from plats -peripheral - venous activity |
| IT1201151B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono |
| US5484594A (en) * | 1988-06-28 | 1996-01-16 | Tecnofarmaci S.P.A. | Process for preparing grapeseed extracts enriched in procyanidol oligomers |
| IT1255029B (it) * | 1992-05-11 | 1995-10-13 | Paolo Morazzoni | Formulazioni farmaceutiche orali contenenti antocianosidi |
| JP2695585B2 (ja) * | 1992-12-28 | 1997-12-24 | キヤノン株式会社 | 光起電力素子及びその製造方法、並びにそれを用いた発電装置 |
| US5536600A (en) * | 1994-09-23 | 1996-07-16 | Kaun; Thomas D. | Li-alloy electrode for Li-alloy/metal sulfide cells |
| FR2750606B1 (fr) * | 1996-07-03 | 1999-01-29 | Maurel Sante | Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant |
| US5912363A (en) * | 1997-08-29 | 1999-06-15 | Interhealth Nutraceuticals | Method for extraction of proanthocyanidins from plant material |
| FR2775686B1 (fr) * | 1998-03-09 | 2006-07-28 | Pascal Commenil | Exploitation industrielle et commerciale des lipides cuticulaires de la baie de raisin en pharmacologie et cosmetologie |
| IT1302365B1 (it) * | 1998-10-09 | 2000-09-05 | Sigma Tau Healthscience Spa | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali |
| US20020192314A1 (en) * | 2001-03-06 | 2002-12-19 | Cho Suk H. | Dietary supplement compositions |
| US6918946B2 (en) * | 2001-07-02 | 2005-07-19 | Board Of Regents, The University Of Texas System | Applications of light-emitting nanoparticles |
| US20030134198A1 (en) * | 2001-09-28 | 2003-07-17 | Kabushiki Kaisha Toshiba | Negative electrode material, negative electrode, nonaqueous electrolyte battery and method of manufacturing a negative electrode material |
-
2001
- 2001-03-13 BR BRPI0106382-0A patent/BRPI0106382B1/pt not_active IP Right Cessation
-
2002
- 2002-03-12 EP EP02702184A patent/EP1368045B1/en not_active Expired - Lifetime
- 2002-03-12 WO PCT/BR2002/000038 patent/WO2002072118A1/en not_active Ceased
- 2002-03-12 US US10/469,990 patent/US20040202737A1/en not_active Abandoned
- 2002-03-12 PT PT02702184T patent/PT1368045E/pt unknown
- 2002-03-12 MX MXPA03008161A patent/MXPA03008161A/es active IP Right Grant
- 2002-03-12 JP JP2002571077A patent/JP2004525124A/ja active Pending
- 2002-03-12 DE DE60213211T patent/DE60213211T2/de not_active Expired - Lifetime
- 2002-03-12 CA CA002440333A patent/CA2440333C/en not_active Expired - Lifetime
- 2002-03-12 AT AT02702184T patent/ATE333283T1/de not_active IP Right Cessation
- 2002-03-12 ES ES02702184T patent/ES2269650T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002072118A1 (en) | 2002-09-19 |
| DE60213211D1 (de) | 2006-08-31 |
| CA2440333C (en) | 2009-02-24 |
| EP1368045B1 (en) | 2006-07-19 |
| MXPA03008161A (es) | 2004-11-12 |
| US20040202737A1 (en) | 2004-10-14 |
| JP2004525124A (ja) | 2004-08-19 |
| PT1368045E (pt) | 2006-12-29 |
| BRPI0106382B8 (https=) | 2021-05-25 |
| ATE333283T1 (de) | 2006-08-15 |
| BR0106382A (pt) | 2003-09-30 |
| DE60213211T2 (de) | 2007-07-19 |
| EP1368045A1 (en) | 2003-12-10 |
| CA2440333A1 (en) | 2002-09-19 |
| ES2269650T3 (es) | 2007-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2352177A (en) | Composition from ginkgo biloba leaves preparation and uses | |
| EP2240193B1 (en) | Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases | |
| ES2705169T3 (es) | Preparación y uso farmacéutico de composiciones de extracto de euterpe oleracea (açaí) | |
| CN105168235A (zh) | 延龄草皂苷类物质及其制剂的制备方法与其在制备治疗老年痴呆及阿尔茨海默病药物中应用 | |
| WO2008004804A1 (en) | Trachelospermi caulis extract composition for the treatment and prevention of inflammatory diseases | |
| KR100834348B1 (ko) | 가죽그물바탕말 추출물을 포함하는 심혈관계 질환의 예방및 치료용 조성물 | |
| BRPI0106382B1 (pt) | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions | |
| US6984405B1 (en) | Compositions for inducing secretion of insulin-like growth factor-1 | |
| CN104027428B (zh) | 一种中药复方的制备方法及在防治老年痴呆症中的应用 | |
| WO1998032455A1 (en) | The extract of pine needle and the use thereof | |
| KR101384410B1 (ko) | 매실나무 추출물의 조성물 제조에서의 응용 | |
| KR20010019147A (ko) | 삼칠근과 단삼의 혼합 추출물을 포함하는 고혈압 치료 및 콜레스테롤 저하 조성물 및 그의 제조 방법 | |
| CA2255668C (en) | Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use | |
| CN101190280B (zh) | 梅树非果部分提取物的用途 | |
| WO2009076869A1 (zh) | 高纯度丹酚酸、制备方法及应用 | |
| US20090317495A1 (en) | Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases | |
| JP2004352626A (ja) | 植物由来成分を含有する抗コレステロール剤 | |
| Tuem et al. | Effect of aqueous and methanolic extracts of Solanum aethiopicum Linn Gilo (Solanaceae) leaves on body weight and Glycemia in rats with alloxan-induced diabetes | |
| JP3157728B2 (ja) | 糖尿病治療薬 | |
| US20030157208A1 (en) | Cynomoriaceae extract and use in treating erectile dysfunction | |
| KR0179088B1 (ko) | 홍경천 추출물을 함유하는 당뇨병 예방 및 치료제 조성물 | |
| US20070218151A1 (en) | Process for obtention of decoctions of Vitis labrusca and Vitis vinifera skins | |
| KR101093731B1 (ko) | 맥문동추출물을 유효성분으로 포함하는 염증성 질환 치료 및 예방용 조성물 | |
| CN110946894B (zh) | 一种治疗肺动脉高压的藏药及其制备方法和应用 | |
| KR100247568B1 (ko) | 동맥경화억제용 약제조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B04C | Request for examination: application reinstated [chapter 4.3 patent gazette] | ||
| B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENTE A PETICAO NO 018050056423/SP DE 25/11/2005. |
|
| B04Z | Request for examination: publication of reinstatement cancelled [chapter 4.3.1 patent gazette] |
Free format text: REFERENTE A RPI NO 1838 DE 28/03/2006. |
|
| B04C | Request for examination: application reinstated [chapter 4.3 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/78 , A61P 9/12 , A61P 9/08 Ipc: A61K 36/87 (2006.01), A61P 9/12 (2006.01), A61K 13 |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/07/2017, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/03/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 13/03/2021 |